Delivery Order SPE2DB24D3013-SPE2DB24FFFZU
Award Date
7/2/24
Potential Completion Date
7/24/24
Potential Value
$8.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a total ceiling value of $13,971.12 and an ultimate completion date of August 2, 2024. The contract is a delivery order, with a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,328.52 and an ultimate completion date of July 10, 2024. It is a firm-fixed-price Delivery Order contract, without a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $4,074.91 for the supply of 200-unit vials of Botox. The award was made by the Defense Logistics Agency (DLA) on June 11, 2024, with a completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
The U.S. Defense Logistics Agency (DLA) awarded a $2,910.65 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 200-unit vials of BOTOX. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between DLA Troop Support Medical and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
Amerisourcebergen Drug Corp, a for-profit global pharmaceutical company, has been awarded a Firm Fixed Price Delivery Order contract worth $3,492.78 from the Defense Logistics Agency (DLA) to provide 200 unit vials of BOTOX. The contract has a completion date of March 15, 2024 and was awarded on February 23, 2024. This award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA, which serves as the primary vehicle for the company to deliver pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA). The $36,092.06 firm fixed price contract has a completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government medical product contracts, particularly with the Department of Defense (DoD) and Department of Veterans Affairs (VA). The...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BOTOX 200 unit vials to the U.S. government. The $4,657.04 firm-fixed price contract was awarded on June 26, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). This is a delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a $61,123.65 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of 200-unit vials of BOTOX. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation that serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies. The award is a firm fixed price delivery order for 4,563,856,643 units of BOTOX 200 with a potential value of $3,492.78 and a performance period through March 22, 2024. This award is not associated with any set-aside...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 200 unit vials of BOTOX to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award has a ceiling value of $13,971.12 and is structured as a firm-fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...